Metabolic Support in Midlife
Perimenopause and Menopause Weight Management with GLP-1
Hormonal shifts during perimenopause and menopause can lead to insulin resistance and a sudden metabolic slowdown. GLP-1 therapies like semaglutide and tirzepatide provide a powerful tool to address these physiological changes, helping you manage weight and restore your metabolic health during this transition.
Why Is Weight Loss More Difficult During Perimenopause and Menopause?
As estrogen levels begin to change, many women notice weight gain despite maintaining the same eating habits and activity level. Hormonal shifts can affect metabolism, body composition, insulin sensitivity, sleep, and appetite regulation, making weight management more challenging.
Common Symptoms That Can Affect Weight Management
✔ Weight gain around the abdomen
✔ Increased hunger or food cravings
✔ Slower metabolism
✔ Fatigue or low energy
✔ Sleep disturbances
✔ Hot flashes
✔ Mood changes
✔ Loss of muscle mass
✔ Difficulty losing weight despite healthy habits
Our Personalized Weight Loss Approach
Every patient receives an individualized treatment plan based on their health history, symptoms, lifestyle, and goals.
- Treatment may include:
- Comprehensive medical evaluation
- GLP-1 medication evaluation when appropriate
- Support for insulin resistance and metabolic health
- Ongoing follow-up and medication adjustments
- Long-term weight maintenance planning
Can GLP-1 Medications Help During Menopause?
For eligible patients, GLP-1–based medications may be considered as part of a comprehensive medical weight-management plan. These medications can help regulate appetite, improve satiety, and support meaningful weight loss when combined with appropriate nutrition and lifestyle habits. Medication isn't right for everyone. Your medical history, current medications, weight-related health conditions, goals, and potential risks are reviewed before treatment is recommended.